HIKAL
Quarterly Results Analysis [Jun2025]
HIKAL Quarterly Results
| Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹380 Cr | ₹552 Cr | ₹448 Cr | ₹453 Cr | ₹407 Cr | ₹514 Cr | ₹448 Cr | ₹435 Cr |
| Expenses | ₹355 Cr | ₹429 Cr | ₹376 Cr | ₹378 Cr | ₹349 Cr | ₹420 Cr | ₹383 Cr | ₹377 Cr |
| Operating Income | ₹25 Cr | ₹123 Cr | ₹72 Cr | ₹75 Cr | ₹58 Cr | ₹94 Cr | ₹65 Cr | ₹58 Cr |
| Other Income | ₹1 Cr | ₹1 Cr | ₹4 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
| Interest | ₹17 Cr | ₹18 Cr | ₹19 Cr | ₹19 Cr | ₹20 Cr | ₹15 Cr | ₹14 Cr | ₹13 Cr |
| Depreciation | ₹39 Cr | ₹38 Cr | ₹33 Cr | ₹32 Cr | ₹32 Cr | ₹32 Cr | ₹29 Cr | ₹29 Cr |
| Profit Before Tax | ₹-30 Cr | ₹68 Cr | ₹24 Cr | ₹25 Cr | ₹7 Cr | ₹47 Cr | ₹22 Cr | ₹17 Cr |
| Profit After Tax | ₹-22 Cr | ₹50 Cr | ₹17 Cr | ₹18 Cr | ₹5 Cr | ₹34 Cr | ₹16 Cr | ₹13 Cr |
| EPS | ₹-1.81 | ₹4.06 | ₹1.39 | ₹1.48 | ₹0.41 | ₹2.74 | ₹1.30 | ₹1.02 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HIKAL | -0.5% | -5.4% | -33.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | 3.6% | -7.8% |
| DIVIS LABORATORIES | 4.4% | 15.9% | 15.6% |
| CIPLA | -4.9% | -0.8% | 6.6% |
| TORRENT PHARMACEUTICALS | -0.6% | 1.8% | 15.7% |
| DR REDDYS LABORATORIES | -4.1% | -3.8% | -4.3% |
| MANKIND PHARMA | -3.1% | -3.3% | -8.6% |
| ZYDUS LIFESCIENCES | -2.9% | -1.6% | -0.5% |
| LUPIN | 2.1% | 1.3% | -8% |
HIKAL Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -31.14 % |
| Y-o-Y | -6.49 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2025 | ₹380 Cr | -31.14 | |
| Mar2025 | ₹552 Cr | 23.39 | |
| Dec2024 | ₹448 Cr | -1.15 | |
| Sep2024 | ₹453 Cr | 11.33 | |
| Jun2024 | ₹407 Cr | -20.87 | |
| Mar2024 | ₹514 Cr | 14.88 | |
| Dec2023 | ₹448 Cr | 2.90 | |
| Sep2023 | ₹435 Cr | - | |
HIKAL Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -79.66 % |
| Y-o-Y | -56.72 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2025 | ₹25 Cr | -79.66 | |
| Mar2025 | ₹123 Cr | 71.15 | |
| Dec2024 | ₹72 Cr | -3.74 | |
| Sep2024 | ₹75 Cr | 29.14 | |
| Jun2024 | ₹58 Cr | -38.56 | |
| Mar2024 | ₹94 Cr | 45.90 | |
| Dec2023 | ₹65 Cr | 12.33 | |
| Sep2023 | ₹58 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -70.46 % |
| Y-o-Y | -53.72 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2025 | 6.6% | -70.46 | |
| Mar2025 | 22.34% | 38.76 | |
| Dec2024 | 16.1% | -2.66 | |
| Sep2024 | 16.54% | 15.99 | |
| Jun2024 | 14.26% | -22.33 | |
| Mar2024 | 18.36% | 26.97 | |
| Dec2023 | 14.46% | 9.21 | |
| Sep2023 | 13.24% | - | |
HIKAL Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2025 | ₹-22 Cr | Negative | |
| Mar2025 | ₹50 Cr | 191.86 | |
| Dec2024 | ₹17 Cr | -6.01 | |
| Sep2024 | ₹18 Cr | 258.82 | |
| Jun2024 | ₹5 Cr | -84.96 | |
| Mar2024 | ₹34 Cr | 110.56 | |
| Dec2023 | ₹16 Cr | 27.78 | |
| Sep2023 | ₹13 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2025 | -5.89 % | Negative | |
| Mar2025 | 9.09 % | 136.72 | |
| Dec2024 | 3.84 % | -4.95 | |
| Sep2024 | 4.04 % | 223.20 | |
| Jun2024 | 1.25 % | -81.03 | |
| Mar2024 | 6.59 % | 83.06 | |
| Dec2023 | 3.6 % | 24.14 | |
| Sep2023 | 2.9 % | - | |
HIKAL Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2025 | ₹-1.81 | Negative | |
| Mar2025 | ₹4.06 | 192.09 | |
| Dec2024 | ₹1.39 | -6.08 | |
| Sep2024 | ₹1.48 | 260.98 | |
| Jun2024 | ₹0.41 | -85.04 | |
| Mar2024 | ₹2.74 | 110.77 | |
| Dec2023 | ₹1.3 | 27.45 | |
| Sep2023 | ₹1.02 | - | |
You may also like the below Video Courses